Am J Hematol

1. BARTLETT NL, Sehn LH, Assouline S, Giri P, et al
   Fixed-Duration Subcutaneous Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma: Pivotal Phase 2 Primary Analysis.
   Am J Hematol. 2026 Mar 20. doi: 10.1002/ajh.70225.
   

   >> Share

   
   
2. SHOUSE G, Matasar M, Chen L, Crombie J, et al
   Polatuzumab Vedotin Combined With R-ICE (PolaR-ICE) as Second-Line Therapy in Diffuse Large B-Cell Lymphoma.
   Am J Hematol. 2026 Mar 17. doi: 10.1002/ajh.70282.
   

   >> Share

   
   
3. VERHAAR W, Weverling F, Khwaja J, Trajanova D, et al
   Zanubrutinib in AL Amyloidosis Associated With Waldenstrom Macroglobulinemia and Other B-Cell Non-Hodgkin Lymphoma.
   Am J Hematol. 2026 Mar 16. doi: 10.1002/ajh.70267.
   

   >> Share

   
   

   
   Blood

4. 
   HOD08 for low-risk pediatric Hodgkin lymphoma.
   Blood. 2026;147:1381.
   

   >> Share

   
   
5. KAULEN LD, Nayak L, Karschnia P, Kraai I, et al
   Immunodeficiency-associated primary CNS lymphomas: An International Primary CNS Lymphoma Collaborative Group (IPCG) Study.
   Blood. 2026 Mar 17:blood.2025031869. doi: 10.1182/blood.2025031869.
   

   >> Share

   
   
6. OERTEL M, Dabaja BS, Gorlich D, Thomas BR, et al
   Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis.
   Blood. 2026 Mar 13:blood.2025032050. doi: 10.1182/blood.2025032050.
   

   >> Share

   
   

   
   BMC Cancer

7. KAPLAN KILIC S, Kiykim A, Burtecene N, Genc DB, et al
   Evaluating functional hyposplenism in pediatric hodgkin lymphoma: the role of marginal zone b cells post-radiotherapy.
   BMC Cancer. 2026 Mar 20. doi: 10.1186/s12885-026-15722.
   

   >> Share

   
   

   
   Br J Haematol

8. SOLOW M, Owen C, Stewart C, Cao JQ, et al
   Limited diagnostic utility of bone marrow sampling in PET-defined limited-stage follicular lymphoma.
   Br J Haematol. 2026 Mar 17. doi: 10.1111/bjh.70440.
   

   >> Share

   
   
9. BAGNOLI F, Calabrese De Feo J, Ricci F, Corrado F, et al
   Bendamustine in combination with gemcitabine and vinorelbine as salvage regimen for relapsed or refractory peripheral T-cell lymphomas: A retrospective single-centre experience.
   Br J Haematol. 2026;208:916-925.
   

   >> Share

   
   
10. STADLER R, Quaglino P, Roccuzzo G
    How I manage mycosis fungoides and Sezary syndrome: Current controversies and unmet needs.
    Br J Haematol. 2026;208:864-873.
    

    >> Share

    
    
11. MATOS DM
    Lymph node biopsy indications: Challenges in determining the 'when'.
    Br J Haematol. 2026;208:837-840.
    

    >> Share

    
    

    
    Haematologica

12. STUVER R, Tang H, Dogan A, Epstein-Peterson ZD, et al
    Non-JAK-family gene fusions in cutaneous T-cell lymphoma highlights genetic diversity and potential therapeutic targets.
    Haematologica. 2026 Mar 19. doi: 10.3324/haematol.2025.300064.
    

    >> Share

    
    
13. SUNDER-PLASSMANN V, Kiesewetter B, Simonitsch-Klupp I, Brand R, et al
    Histological response dynamics in gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue after helicobacter-pylori eradication: a singlecenter longitudinal analysis.
    Haematologica. 2026 Mar 19. doi: 10.3324/haematol.2025.300054.
    

    >> Share

    
    
14. RAMDIAL J, Agbadiba E, Hawkins M, Ayers A, et al
    Salvage high-dose chemotherapy and autologous stem cell transplant consolidation following relapse after CAR-T cell for large B-cell lymphoma.
    Haematologica. 2026 Mar 19. doi: 10.3324/haematol.2025.300402.
    

    >> Share

    
    
15. TEMBRINK M, Haverkamp T, Reinhardt HC, Hanoun M, et al
    Peripheral T-cell lymphoma in adult-onset familial hemophagocytic lymphohistiocytosis type 2 and heterozygous LRBA mutation.
    Haematologica. 2026 Mar 19. doi: 10.3324/haematol.2026.300514.
    

    >> Share

    
    

    
    Hum Pathol

16. ABU MEHSEN S, Monika F, Sharma S, Idiaquez DW, et al
    Absence of CD38 expression in mantle cell lymphoma correlates with distinct pathological and genetic features.
    Hum Pathol. 2026;172:106107.
    

    >> Share

    
    

    
    J Immunol

17. MELER A, Gusi-Vives M, de Barrios O, Azagra A, et al
    HDAC7 is a key factor for the germinal center reaction and its underexpression is associated with DLBCL prognosis.
    J Immunol. 2026;215:vkag015.
    

    >> Share

    
    

    
    Leuk Lymphoma

18. TRABOLSI A, Plate TE, Lavorgna T, Kronenfeld RS, et al
    Predictors and timing of venous thromboembolism and overall survival in lymphoma.
    Leuk Lymphoma. 2026 Mar 20:1-9. doi: 10.1080/10428194.2026.2644580.
    

    >> Share

    
    
19. SUKE SG, Wong C, Yannakou CK
    Secondary graft failure after autologous stem cell transplantation for primary central nervous system lymphoma responds to ciclosporin and eltrombopag.
    Leuk Lymphoma. 2026 Mar 19:1-3. doi: 10.1080/10428194.2026.2643746.
    

    >> Share

    
    
20. KIM WS, Al Mansour M, Cheah C, de Holanda Farias JS, et al
    Tailored approaches in mantle cell lymphoma: refining treatment paradigms with an expert panel opinion.
    Leuk Lymphoma. 2026 Mar 17:1-11. doi: 10.1080/10428194.2026.2640453.
    

    >> Share

    
    
21. BAYOUMI MA, Arafah OS, Khalil EM, Kotb MH, et al
    Response-adapted de-escalation of radiotherapy in pediatric Hodgkin's lymphoma.
    Leuk Lymphoma. 2026 Mar 14:1-9. doi: 10.1080/10428194.2026.2642233.
    

    >> Share

    
    

    
    Leukemia

22. CHEN Z, Ruan Y, Wang Y, Liu F, et al
    Validation of Prospective Cutaneous Lymphoma International Prognostic Index for advanced cutaneous lymphoma in a multicenter Chinese cohort.
    Leukemia. 2026 Mar 20. doi: 10.1038/s41375-026-02927.
    

    >> Share

    
    

    
    Neurology

23. MULLER KJ, Karschnia P, Kaulen LD, Reis J, et al
    Clinical Manifestations of Primary CNS T-Cell Lymphoma: A Retrospective Study of Histopathologic, Molecular, and Neuroimaging Features.
    Neurology. 2026;106:e214744.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share